Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CHKA | P35790 | 8/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | DRD4 | P21917 | 3/20 | 0.41 |
| ▸ | DRD3 | P35462 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzylimidazole SCHEMBL3786784 | 0.98 | ALDH1A1 (0.44) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Benzylimidazole SCHEMBL1123480 | 0.98 | ALDH1A1 (0.49) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Benzylimidazole SCHEMBL16237306 | 0.98 | CHKA (0.46) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Benzylimidazole SCHEMBL16699274 | 0.89 | ALDH1A1 (0.47) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Benzylimidazole SCHEMBL16237033 | 0.89 | FDPS (0.43) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Benzylimidazole SCHEMBL3418783 | 0.89 | ALDH1A1 (0.46) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Benzylimidazole SCHEMBL16237353 | 0.88 | ALDH1A1 (0.41) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Benzylimidazole SCHEMBL7942344 | 0.88 | ALDH1A1 (0.41) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Benzylimidazole SCHEMBL16236716 | 0.87 | ALDH1A1 (0.41) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Benzylimidazole SCHEMBL28855087 | 0.87 | NPSR1 (0.40) | ALDH1A1KDM4ERAB9ACHKALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250196021-A1 | METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-06-19 | — | — | US | claimed |
| WO-2025128828-A1 | METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-06-19 | — | — | WO | claimed |
| EP-3802423-B1 | METHODS OF PREPARING CRYSTALLINE GERMANOSILICATE MATERIALS OF CIT-13 TOPOLOGY | CALIFORNIA INST OF TECHN (US) | 2025-04-02 | — | — | EP | claimed |
| WO-2024182910-A1 | REVERSIBLE PHOTOSWITCHABLE SUPRAMOLECULAR STRUCTURE THAT CHANGES ITS FORM OR ACTIVITY WHEN EXPOSED TO LIGHT; SYNTHESIS PROCESS; AND USES | UNIVERSIDAD AUTÓNOMA DE CHILE (CL) | 2024-09-12 | — | — | WO | claimed |
| US-11949136-B2 | PH-gradient-enabled microscale bipolar interfaces for direct liquid-fuel/oxidant fuel cells | WASHINGTON UNIVERSITY (US) | 2024-04-02 | — | — | US | claimed |
| CN-115297963-B | Geosilicate CIT-14/IST and preparation thereof from Geosilicate CIT-13/OH | 加州理工学院 | 2023-12-26 | — | — | CN | claimed |
| US-11616246-B2 | Microscale-bipolar-interface-enabled pH gradients in electrochemical devices | WASHINGTON UNIVERSITY (US) | 2023-03-28 | — | — | US | claimed |
| US-20230032494-A1 | GERMANOSILICATE CIT-14/IST AND ITS PREPARATION FROM GERMANOSILICATE CIT-13/OH | CHEVRON USA INC. | 2023-02-02 | — | — | US | claimed |
| CN-115297963-A | Germanosilicate CIT-14/IST and preparation thereof from germanosilicate CIT-13/OH | 加州理工学院 | 2022-11-04 | — | — | CN | claimed |
| EP-3611760-B1 | COMPOSITES WITH ENHANCED THERMAL CONDUCTIVITY AND METHOD PREPARING THE SAME | KOREA INST SCI & TECH (KR) | 2022-10-05 | — | — | EP | claimed |
| US-20160346771-A1 | CRYSTALLINE GERMANOSILICATE MATERIALS OF NEW CIT-13 TOPOLOGY AND METHODS OF PREPARING THE SAME | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-12-01 | — | — | US | claimed |
| US-20160263562-A1 | METHODS TO PRODUCE MOLECULAR SIEVES WITH LTA TOPOLOGY AND COMPOSITIONS DERIVED THEREFROM | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-09-15 | — | — | US | claimed |
| US-20150133711-A1 | Separations With Ionic Liquid Solvents | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2015-05-14 | — | — | US | claimed |
| US-8956445-B2 | High stability diionic liquid salts | SIGMA-ALDRICH CO. (US) | 2015-02-17 | — | — | US | claimed |
| US-20120211696-A1 | HIGH STABILITY DIIONIC LIQUID SALTS | SIGMA-ALDRICH CO. LLC (US) | 2012-08-23 | — | — | US | claimed |
| US-8168830-B2 | use of these novel ionic liquids having bis-cation or bis-anion separated by bridging group as the stationary phase in a gas chromatographic column | SIGMA-ALDRICH CO. LLC (US) | 2012-05-01 | — | — | US | claimed |
| WO-2010085638-A1 | OLEFIN METATHESIS CATALYTIC SYSTEM | PHENOMIX CORPORATION (US) | 2010-07-29 | — | — | WO | claimed |
| EP-0081679-B1 | SUBSTITUTED BENZYLIMIDAZOLIUM SALTS AND MICROBICIDES CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1986-01-29 | — | — | EP | claimed |
| US-4481211-A | BACTERICIDES, FUNGICIDES, ALGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1984-11-06 | — | — | US | claimed |
| EP-0081679-A2 | Substituted benzylimidazolium salts and microbicides containing them | BASF Aktiengesellschaft (DE) | 1983-06-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160346771-A1 | CRYSTALLINE GERMANOSILICATE MATERIALS OF NEW CIT-13 TOPOLOGY AND METHODS OF PREPARING THE SAME | ATG13, SLC13A3, MICOS13 | ALDH1A1 4482/4885KDM4E 3843/4885RAB9A 1292/4885 |
| US-20160263562-A1 | METHODS TO PRODUCE MOLECULAR SIEVES WITH LTA TOPOLOGY AND COMPOSITIONS DERIVED THEREFROM | LTA, NOXO1, ALOX12 | ALDH1A1 334/4885KDM4E 4727/4885RAB9A 687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.